Cronos (CRON) Interest & Investment Income (2019 - 2026)
Cronos (CRON) recorded quarterly Interest & Investment Income of $8.9 million in Q1 2026, down 7.39% quarter-over-quarter from $9.6 million in Q4 2025, and down 8.4% on a YoY basis from $9.7 million in Q1 2025.
Cronos (CRON) Interest & Investment Income (2019 - 2026) Analysis & Trends
Cronos' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 8.4% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $39.2 million (down 17.47% YoY), while the FY2025 annual figure was $40.0 million, down 23.18% from the prior year.
- Interest & Investment Income was $8.9 million for Q1 2026 at Cronos, down from $9.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $14.2 million in Q1 2024 to a low of $2.0 million in Q1 2022.
- Historically, Interest & Investment Income has averaged $10.3 million across 5 years, with a median of $11.2 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 446.19% in 2023, then sank 33.11% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $9.5 million in 2022, then surged by 49.84% to $14.2 million in 2023, then fell by 16.54% to $11.9 million in 2024, then declined by 19.42% to $9.6 million in 2025, then retreated by 7.39% to $8.9 million in 2026.
- The last three Interest & Investment Income figures came in at $8.9 million (Q1 2026), $9.6 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 8.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.85 Mn |
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.67 Mn |
| Dec 31, 2024 | 11.86 Mn |
| Sep 30, 2024 | 12.46 Mn |
| Jun 30, 2024 | 13.45 Mn |
| Mar 31, 2024 | 14.25 Mn |
| Dec 31, 2023 | 14.21 Mn |
| Sep 30, 2023 | 13.38 Mn |
| Jun 30, 2023 | 12.47 Mn |
| Mar 31, 2023 | 11.18 Mn |
| Dec 31, 2022 | 9.49 Mn |
| Sep 30, 2022 | 7.21 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 2.29 Mn |